Notice Of 45Th Annual General Meeting To Be Held On September 29, 2018 At 11.00 A.M.
This is to inform you that the 45th Annual General Meeting of the members of the Company will be held on Saturday, 29th September, 2018 at 11.00 a.m. at 608, Marathon Max, Mulund Goregaon Link Road, Mulund (West), Mumbai - 400080 (Maharashtra). Shareholding for the Period Ended August 24, 2018
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended August 24, 2018. For more details, kindly Click here Announcement under Regulation 30 (LODR)-Acquisition
We would like to inform you that the Company has executed a Business Transfer Agreement and other related documents ('Agreement') with M/s. Om Diagnostics Lab Private Limited ('Om Diagnostics') and ultimate promoters of Om Diagnostics inter-alia for acquisition of business of Om Diagnostics on the terms and conditions more specifically defined in the Agreement.... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paresh Bhanushali Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Geeta Bhanushali, Vinod Bhanushali HUF, Yashraj Biotechnology Ltd, Arvind Bhanushali, Paresh Bhanushali & Rinku Bhanushali & Vinod Bhanushali Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rinku Bhanushali Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Bhanushali Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Bhanushali HUF Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yash Raj Biotechnology Ltd Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Geeta Bhanushali